BSE Live
May 21, 16:00Prev. Close
6.29
Open Price
6.29
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
May 21, 15:57Prev. Close
6.40
Open Price
6.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
6.40 (235962)
| Key Financial Ratios of Dr. Datson Labs (in Rs. Cr.) | Mar 09 | Mar 08 | Mar 07 | |
| Per Share Ratios | ||||
| Basic EPS (Rs.) | 10.26 | 11.60 | 0.00 | |
| Diluted EPS (Rs.) | 10.26 | 11.60 | 0.00 | |
| Cash EPS (Rs.) | 11.30 | 14.48 | 0.00 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 24.88 | 21.44 | -21.90 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 24.88 | 21.44 | -21.90 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 182.09 | 109.39 | 0.00 | |
| PBDIT/Share (Rs.) | 22.04 | 23.58 | 0.00 | |
| PBIT/Share (Rs.) | 20.99 | 22.44 | 0.00 | |
| PBT/Share (Rs.) | 15.78 | 18.53 | 0.00 | |
| Net Profit/Share (Rs.) | 10.26 | 11.60 | 0.00 | |
| Profitability Ratios | ||||
| PBDIT Margin (%) | 12.10 | 21.55 | 0.00 | |
| PBIT Margin (%) | 11.52 | 20.51 | 0.00 | |
| PBT Margin (%) | 8.66 | 16.94 | 0.00 | |
| Net Profit Margin (%) | 5.63 | 10.59 | 0.00 | |
| Return on Networth / Equity (%) | 41.22 | 54.09 | 0.00 | |
| Return on Capital Employed (%) | 9.96 | 13.26 | 0.00 | |
| Return on Assets (%) | 8.36 | 8.40 | 0.00 | |
| Total Debt/Equity (X) | 3.06 | 2.90 | -24.79 | |
| Asset Turnover Ratio (%) | 148.48 | 79.27 | 0.00 | |
| Liquidity Ratios | ||||
| Current Ratio (X) | 4.87 | 1.66 | 0.24 | |
| Quick Ratio (X) | 3.29 | 1.38 | 0.24 | |
| Inventory Turnover Ratio (X) | 5.88 | 7.83 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | |
| Valuation Ratios | ||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 100.00 | 100.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 |
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
02.04.2026
02.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth